A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors

Kevin A. Schulman, Damon M. Seils, Justin W. Timbie, Jeremy Sugarman, Lauren A. Dame, Kevin P. Weinfurt, Daniel B. Mark, M. Robert

Research output: Contribution to journalArticle

Abstract

Background: Concerned about threats to the integrity of clinical trials in a research environment increasingly controlled by private interests, the International Committee of Medical Journal Editors (ICMJE) has issued revised guidelines for investigators' participation in the study design, access to data, and control over publication. It is unclear whether research conducted at academic institutions adheres to these new standards. Methods: From November 2001 through January 2002, we interviewed officials at U.S. medical schools about provisions in their institutions' agreements with industry sponsors of multicenter clinical trials. A subgroup of the respondents were also asked about coordinating-center agreements for such trials. Results: Of the 122 medical schools that are members of the Association of American Medical Colleges, 108 participated in the survey. The median number of site-level agreements executed per institution in the previous year was 103 (interquartile range, 50 to 210). Scores for compliance with a wide range of provisions - from ensuring that authors of reports on multicenter trials have access to all trial data (1 percent [interquartile range, 0 to 21]) to addressing the plan for data collection and monitoring (10 percent [interquartile range, 1 to 50]) - demonstrated limited adherence to the standards embodied in the new ICMJE guidelines. Scores for coordinating-center agreements were somewhat higher for most survey items. Conclusions: Academic institutions routinely engage in industry-sponsored research that fails to adhere to ICMJE guidelines regarding trial design, access to data, and publication rights. Our findings suggest that a reevaluation of the process of contracting for clinical research is urgently needed.

Original languageEnglish (US)
Pages (from-to)1335-1341
Number of pages7
JournalNew England Journal of Medicine
Volume347
Issue number17
DOIs
StatePublished - Oct 24 2002
Externally publishedYes

Fingerprint

Medical Schools
Industry
Clinical Trials
Guidelines
Research
Multicenter Studies
Publications
Controlled Environment
American Medical Association
Research Personnel
Surveys and Questionnaires

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. / Schulman, Kevin A.; Seils, Damon M.; Timbie, Justin W.; Sugarman, Jeremy; Dame, Lauren A.; Weinfurt, Kevin P.; Mark, Daniel B.; Robert, M.

In: New England Journal of Medicine, Vol. 347, No. 17, 24.10.2002, p. 1335-1341.

Research output: Contribution to journalArticle

Schulman, KA, Seils, DM, Timbie, JW, Sugarman, J, Dame, LA, Weinfurt, KP, Mark, DB & Robert, M 2002, 'A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors', New England Journal of Medicine, vol. 347, no. 17, pp. 1335-1341. https://doi.org/10.1056/NEJMsa020349
Schulman, Kevin A. ; Seils, Damon M. ; Timbie, Justin W. ; Sugarman, Jeremy ; Dame, Lauren A. ; Weinfurt, Kevin P. ; Mark, Daniel B. ; Robert, M. / A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. In: New England Journal of Medicine. 2002 ; Vol. 347, No. 17. pp. 1335-1341.
@article{5476e17cbe864d45814677e10bb2e201,
title = "A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors",
abstract = "Background: Concerned about threats to the integrity of clinical trials in a research environment increasingly controlled by private interests, the International Committee of Medical Journal Editors (ICMJE) has issued revised guidelines for investigators' participation in the study design, access to data, and control over publication. It is unclear whether research conducted at academic institutions adheres to these new standards. Methods: From November 2001 through January 2002, we interviewed officials at U.S. medical schools about provisions in their institutions' agreements with industry sponsors of multicenter clinical trials. A subgroup of the respondents were also asked about coordinating-center agreements for such trials. Results: Of the 122 medical schools that are members of the Association of American Medical Colleges, 108 participated in the survey. The median number of site-level agreements executed per institution in the previous year was 103 (interquartile range, 50 to 210). Scores for compliance with a wide range of provisions - from ensuring that authors of reports on multicenter trials have access to all trial data (1 percent [interquartile range, 0 to 21]) to addressing the plan for data collection and monitoring (10 percent [interquartile range, 1 to 50]) - demonstrated limited adherence to the standards embodied in the new ICMJE guidelines. Scores for coordinating-center agreements were somewhat higher for most survey items. Conclusions: Academic institutions routinely engage in industry-sponsored research that fails to adhere to ICMJE guidelines regarding trial design, access to data, and publication rights. Our findings suggest that a reevaluation of the process of contracting for clinical research is urgently needed.",
author = "Schulman, {Kevin A.} and Seils, {Damon M.} and Timbie, {Justin W.} and Jeremy Sugarman and Dame, {Lauren A.} and Weinfurt, {Kevin P.} and Mark, {Daniel B.} and M. Robert",
year = "2002",
month = "10",
day = "24",
doi = "10.1056/NEJMsa020349",
language = "English (US)",
volume = "347",
pages = "1335--1341",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "17",

}

TY - JOUR

T1 - A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors

AU - Schulman, Kevin A.

AU - Seils, Damon M.

AU - Timbie, Justin W.

AU - Sugarman, Jeremy

AU - Dame, Lauren A.

AU - Weinfurt, Kevin P.

AU - Mark, Daniel B.

AU - Robert, M.

PY - 2002/10/24

Y1 - 2002/10/24

N2 - Background: Concerned about threats to the integrity of clinical trials in a research environment increasingly controlled by private interests, the International Committee of Medical Journal Editors (ICMJE) has issued revised guidelines for investigators' participation in the study design, access to data, and control over publication. It is unclear whether research conducted at academic institutions adheres to these new standards. Methods: From November 2001 through January 2002, we interviewed officials at U.S. medical schools about provisions in their institutions' agreements with industry sponsors of multicenter clinical trials. A subgroup of the respondents were also asked about coordinating-center agreements for such trials. Results: Of the 122 medical schools that are members of the Association of American Medical Colleges, 108 participated in the survey. The median number of site-level agreements executed per institution in the previous year was 103 (interquartile range, 50 to 210). Scores for compliance with a wide range of provisions - from ensuring that authors of reports on multicenter trials have access to all trial data (1 percent [interquartile range, 0 to 21]) to addressing the plan for data collection and monitoring (10 percent [interquartile range, 1 to 50]) - demonstrated limited adherence to the standards embodied in the new ICMJE guidelines. Scores for coordinating-center agreements were somewhat higher for most survey items. Conclusions: Academic institutions routinely engage in industry-sponsored research that fails to adhere to ICMJE guidelines regarding trial design, access to data, and publication rights. Our findings suggest that a reevaluation of the process of contracting for clinical research is urgently needed.

AB - Background: Concerned about threats to the integrity of clinical trials in a research environment increasingly controlled by private interests, the International Committee of Medical Journal Editors (ICMJE) has issued revised guidelines for investigators' participation in the study design, access to data, and control over publication. It is unclear whether research conducted at academic institutions adheres to these new standards. Methods: From November 2001 through January 2002, we interviewed officials at U.S. medical schools about provisions in their institutions' agreements with industry sponsors of multicenter clinical trials. A subgroup of the respondents were also asked about coordinating-center agreements for such trials. Results: Of the 122 medical schools that are members of the Association of American Medical Colleges, 108 participated in the survey. The median number of site-level agreements executed per institution in the previous year was 103 (interquartile range, 50 to 210). Scores for compliance with a wide range of provisions - from ensuring that authors of reports on multicenter trials have access to all trial data (1 percent [interquartile range, 0 to 21]) to addressing the plan for data collection and monitoring (10 percent [interquartile range, 1 to 50]) - demonstrated limited adherence to the standards embodied in the new ICMJE guidelines. Scores for coordinating-center agreements were somewhat higher for most survey items. Conclusions: Academic institutions routinely engage in industry-sponsored research that fails to adhere to ICMJE guidelines regarding trial design, access to data, and publication rights. Our findings suggest that a reevaluation of the process of contracting for clinical research is urgently needed.

UR - http://www.scopus.com/inward/record.url?scp=0037168015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037168015&partnerID=8YFLogxK

U2 - 10.1056/NEJMsa020349

DO - 10.1056/NEJMsa020349

M3 - Article

C2 - 12397192

AN - SCOPUS:0037168015

VL - 347

SP - 1335

EP - 1341

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 17

ER -